| The biopharmaceutical industry is ideally situated to take
advantage of the power of electronic marketing. Pharma
companies will reap the rewards of developing highly effective,
robust and scaleable electronic marketing programmes designed
to meet today’s challenges.
These hurdles include:
- Escalating competition for innovation
- Promotion of new drugs or other products as soon
as they are out of R&D
- The rapid spread of globalisation requiring immediate
international marketing efforts
- Continually changing regulatory mandates that necessitate
nimble response
- Growing pressure to demonstrate financial performance
despite finite or shrinking budgets
Whether a biotech or pharma business is in start-up mode,
building demand or working toward an exit strategy, electronic
marketing can play a central role in educating the worldwide
market about pharmaceutical breakthroughs, establishing brand
awareness, driving qualified leads, creating customer loyalty
and increasing company valuation. |